Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
47m agoGridAI Technologies Corp. to Present at the Market Movers Investor Summit
47m agoGLENSTAR DRILLING PROGRAM UPDATE AT WILDHORSE PROJECT CURRENTLY UNDERWAY IN NEVADA
50m agoCorning's Angela Haneklau Named Inaugural Recipient of Graybar's WINGS Luminary Award
1h agoIrenic Acquisition Corp. Announces Completion of $220,000,000 Initial Public Offering
1h agoAmericore Resources Announces Non-Brokered Private Placement of $3,000,000

Evommune, Inc.

About

Evommune, Inc. (NYSE:EVMN) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 6 2026
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
Mar 5 2026
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Feb 13 2026
Evommune Announces $125 Million Private Placement
Feb 10 2026
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis
Dec 11 2025
Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update

Financials

Revenue
$13 M
Market Cap
$854.36 M
EPS
-11.22

Community Chat

Ask AI

6ix6ix